These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6553057)

  • 21. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
    Kaplan AP; Silverberg M; Dunn JT; Miller G
    Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
    van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
    Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).
    Chan JY; Burrowes CE; Movat HZ
    Agents Actions; 1978 Jan; 8(1-2):65-72. PubMed ID: 636957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding and dissociation of Hageman factor, prekallikrein and high molecular weight kininogen in human plasma during contact activation.
    Nakahara M
    Biochem Pharmacol; 1980 May; 29(9):1247-54. PubMed ID: 6772195
    [No Abstract]   [Full Text] [Related]  

  • 30. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation mechanism of human Hageman factor-plasma kallikrein-kinin system by Vibrio vulnificus metalloprotease.
    Miyoshi S; Shinoda S
    FEBS Lett; 1992 Aug; 308(3):315-9. PubMed ID: 1380471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular assembly in the contact phase of the Hageman factor system.
    Cochrane CG; Griffin JH
    Am J Med; 1979 Oct; 67(4):657-64. PubMed ID: 386794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hageman factor dependent pathway in local vascular permeability enhancement.
    Yamamoto T; Kozono K; Tsuruta J; Cochrane CG; Kambara T
    Adv Exp Med Biol; 1986; 198 Pt B():45-52. PubMed ID: 3812107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of two kinds of low molecular weight kininogens from rat (non-inflamed) plasma. One resistant and the second sensitive to rat glandular kallikreins.
    Enjyoji K; Kato H; Hayashi I; Oh-ishi S; Iwanaga S
    J Biol Chem; 1988 Jan; 263(2):965-72. PubMed ID: 3335530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein.
    Mori K; Sakamoto W; Nagasawa S
    J Biochem; 1981 Aug; 90(2):503-9. PubMed ID: 6913579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kinin released from high molecular weight-kininogen is responsible for inflammatory exudation in rats: detection of kinin-free-kininogen in the exudate by immunoblot analysis.
    Fujie H; Hayashi I; Oh-ishi S
    Life Sci; 1993; 53(22):1691-701. PubMed ID: 8231650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.